{"news_desk": "Letters", "print_page": "16", "subsection_name": null, "section_name": "Opinion", "byline": [], "abstract": null, "type_of_material": "Letter", "word_count": "203", "keywords": [{"rank": "1", "value": "World Health Organization", "is_major": "N", "name": "organizations"}, {"rank": "2", "value": "United Nations", "is_major": "N", "name": "organizations"}, {"rank": "3", "value": "Drugs (Pharmaceuticals)", "is_major": "N", "name": "subject"}, {"rank": "4", "value": "Inventions and Patents", "is_major": "N", "name": "subject"}], "lead_paragraph": "An executive argues that the world\u2019s innovative biopharmaceutical companies are deeply engaged in finding holistic solutions to access.", "pub_date": "2016-11-21T06:11:06Z", "document_type": "article", "source": "The New York Times", "snippet": "An executive argues that the world\u2019s innovative biopharmaceutical companies are deeply engaged in finding holistic solutions to access....", "multimedia": [], "web_url": "http://www.nytimes.com/2016/11/18/opinion/dont-blame-pharmaceutical-companies.html", "slideshow_credits": null, "blog": [], "_id": "583290007c459f6a5fccf1e1", "headline": {"main": "Don\u2019t Blame Pharmaceutical Companies", "content_kicker": "Letter", "kicker": "Letter"}}